NSAIDs and gastrointestinal cancer prevention

Drugs
Kate JollyMichael J S Langman

Abstract

Numerous studies report the relationship between aspirin and other nonsteroidal anti-inflammatories (NSAIDs) and cancer incidence, in particular for colorectal cancer. This paper systematically reviews the evidence of the effect of aspirin and other NSAIDs on the primary prevention of colorectal and other gastrointestinal cancers in the general population. In 25 investigations of NSAIDs and colorectal cancer, 23 observational studies reported a relative risk reduction but estimates vary widely. Cohort studies generally indicate lesser reductions than case-control studies suggesting possible biases in the latter. Clear evidence of a dose relationship generally appears lacking but data do not indicate useful effects of aspirin in cardioprophylactic doses. Differences have otherwise not been detected between aspirin and other NSAIDs, nor between non-aspirin NSAIDs. There is some evidence that the risk of colorectal cancer reduces with increased duration of NSAID use. The lower incidence of oesophageal and gastric cancers results in smaller numbers of cases in the studies reporting these cancers, particularly in the cohort studies. The trend is for a risk reduction for oesophageal and gastric cancers in people taking NSAIDs, which ...Continue Reading

References

Jan 1, 1978·Journal of Chronic Diseases·H A IsomäkiU Joutsenlahti
Mar 6, 1991·Journal of the National Cancer Institute·L RosenbergS Shapiro
Aug 21, 1991·Journal of the National Cancer Institute·A Paganini-HillB E Henderson
Nov 18, 1989·BMJ : British Medical Journal·A Paganini-HillB E Henderson
Mar 1, 1995·Preventive Medicine·A Paganini-Hill
Sep 7, 1995·The New England Journal of Medicine·E GiovannucciF E Speizer
Nov 1, 1994·Digestive Diseases and Sciences·A D MüllerI H Wasserman
Aug 15, 1994·Annals of Internal Medicine·E GiovannucciW C Willett
Oct 1, 1994·Cancer·J E MuscatE L Wynder
Feb 28, 1994·Archives of Internal Medicine·I I PelegC M Wilcox
Mar 1, 1994·Epidemiology·D M Schreinemachers, R B Everson
Aug 4, 1993·Journal of the National Cancer Institute·P H GannC H Hennekens
Aug 15, 1993·Cancer·O SuhN J Petrelli
May 6, 1993·The New England Journal of Medicine·F M GiardielloG J Offerhaus
Feb 17, 1993·Journal of the National Cancer Institute·G GridleyJ F Fraumeni
Oct 1, 1995·Cancer·E M Funkhouser, G B Sharp
Aug 1, 1996·Carcinogenesis·Y Beazer-BarclayK W Kinzler
Nov 4, 1996·International Journal of Cancer. Journal International Du Cancer·A GaridouD Trichopoulos
Jan 1, 1997·British Journal of Cancer·C La VecchiaA Decarli
Oct 27, 1997·Arthritis and Rheumatism·J CibereM Haga
Dec 16, 1998·Annals of Internal Medicine·T StürmerC H Hennekens
Aug 11, 1998·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·G Morgan, H Vainio
Jul 15, 1999·International Journal of Cancer. Journal International Du Cancer·D ZaridzeV Chkhikvadze
Sep 1, 1999·Clinical Endocrinology·C E MartinelliA C Moreira
Dec 14, 1999·The British Journal of Surgery·A Cairns, P Quirke
May 8, 2000·Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie·N Arber
Jun 1, 2000·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·C BosettiC C Hsieh
Jun 19, 2001·International Journal of Cancer. Journal International Du Cancer·M LiX C Xu

❮ Previous
Next ❯

Citations

May 10, 2006·Investigational New Drugs·Nico JanssensTim Perera
Dec 16, 2003·Life Sciences·Shufeng ZhouEdmund Jon Deoon Lee
Jul 12, 2002·Drug Discovery Today·Burkhard Haefner
Dec 2, 2006·Nature Reviews. Drug Discovery·Nick Barker, Hans Clevers
Oct 2, 2004·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Maryam AsgariMary-Margaret Chren
Feb 13, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·P DursunA Ayhan
Nov 8, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·T A GatcliffeR F Holcombe
Nov 29, 2002·Proceedings of the National Academy of Sciences of the United States of America·Suet Y LeungPatrick O Brown
Apr 9, 2011·Medical Education Online·Britta M ThompsonElizabeth A Nelson
Dec 9, 2008·European Journal of Gastroenterology & Hepatology·Carina PereiraMário J Dinis-Ribeiro
Aug 13, 2009·Digestive Diseases and Sciences·Ping YangXiao-Ting Wu
Apr 14, 2010·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Wenjing TianXin Li
Jul 19, 2011·Toxicology and Applied Pharmacology·Raafat A El-AwadyAbeer M Elsayed
Mar 31, 2009·Lancet·Peter C ElwoodGareth Morgan
Aug 30, 2007·Phytotherapy Research : PTR·Priyadarshini RamanMuraleedharan G Nair
Nov 9, 2005·Peptides·Paula C EvesJohn W Haycock
Feb 23, 2017·Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquée, Nutrition Et Métabolisme·Nitin ShivappaReema Tayyem
Nov 7, 2017·Medicinal Chemistry Research : an International Journal for Rapid Communications on Design and Mechanisms of Action of Biologically Active Agents·Bini MathewRobert C Reynolds
Nov 17, 2004·British Journal of Cancer·R D BrammerM C Eggo
May 24, 2006·World Journal of Gastroenterology : WJG·Yun Dai, Wei-Hong Wang
Dec 16, 2006·World Journal of Gastroenterology : WJG·Hong-Chuan ZhaoGui-Hua Chen
Dec 4, 2019·Frontiers in Oncology·Kendall L LangstenJaime F Modiano
Oct 26, 2021·Inorganic Chemistry·Katrina M MirandaDavid A Wink

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.